icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts 1Q 2011 net profit of 338.3 million roubles

Veropharm posts 1Q 2011 net profit of 338.3 million roubles
Leading Russian pharmaceutical producer, Veropharm, has posted a 1Q 2011 net profit of 338.3 million roubles under IFRS.

The bottom line was up 179% from the 121.2 million roubles net result posted for 1Q 2010, with EBITDA up 109% year on year, to reach 415.5 million roubles, on the back of revenues increasing 43.6% to 1.4 billion roubles from 962.9 million roubles a year ago.

The company said the result reflected increasing business efficiency despite a higher tax environment, and noted the 61% increase in Rx drug sales as a key contributor to revenue growth.

Podcasts